Global Trust Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.1K | Sell |
821
-14,290
| -95% | -$1.37M | 0.03% | 225 |
|
|
2025
Q4 | $1.45M | Buy |
15,111
+11,648
| +336% | +$1.13M | 0.57% | 44 |
|
|
2025
Q3 | $330K | Buy |
3,463
+548
| +19% | +$50.4K | 0.15% | 125 |
|
|
2025
Q2 | $254K | Sell |
2,915
-33
| -1% | -$2.8K | 0.14% | 135 |
|
|
2025
Q1 | $265K | Sell |
2,948
-394
| -12% | -$35.3K | 0.16% | 123 |
|
|
2024
Q4 | $267K | Sell |
3,342
-323
| -9% | -$28K | 0.1% | 146 |
|
|
2024
Q3 | $330K | Buy |
3,665
+259
| +8% | +$21.8K | 0.12% | 137 |
|
|
2024
Q2 | $268K | Buy |
3,406
+258
| +8% | +$21.2K | 0.11% | 144 |
|
|
2024
Q1 | $274K | Buy |
3,148
+1,409
| +81% | +$120K | 0.11% | 139 |
|
|
2023
Q4 | $143K | Sell |
1,739
-85
| -5% | -$6.48K | 0.06% | 168 |
|
|
2023
Q3 | $143K | Buy |
1,824
+58
| +3% | +$4.86K | 0.07% | 161 |
|
|
2023
Q2 | $156K | Buy |
1,766
+23
| +1% | +$1.98K | 0.07% | 157 |
|
|
2023
Q1 | $141K | Buy |
1,743
+782
| +81% | +$63.7K | 0.07% | 163 |
|
|
2022
Q4 | $74.7K | Sell |
961
-5
| -0.5% | -$405 | 0.04% | 199 |
|
|
2022
Q3 | $78K | Sell |
966
-110
| -10% | -$9.88K | 0.04% | 192 |
|
|
2022
Q2 | $97K | Sell |
1,076
-185
| -15% | -$18.7K | 0.05% | 191 |
|
|
2022
Q1 | $140K | Hold |
1,261
| – | – | 0.06% | 204 |
|
|
2021
Q4 | $130K | Sell |
1,261
-150
| -11% | -$17.4K | 0.05% | 206 |
|
|
2021
Q3 | $177K | Sell |
1,411
-70
| -5% | -$9.06K | 0.08% | 174 |
|
|
2021
Q2 | $184K | Buy |
1,481
+100
| +7% | +$12.6K | 0.09% | 176 |
|
|
2021
Q1 | $163K | Hold |
1,381
| – | – | 0.09% | 169 |
|
|
2020
Q4 | $162K | Hold |
1,381
| – | – | 0.09% | 178 |
|
|
2020
Q3 | $141K | Hold |
1,381
| – | – | 0.09% | 157 |
|
|
2020
Q2 | $127K | Sell |
1,381
-26
| -2% | -$2.49K | 0.09% | 149 |
|
|
2020
Q1 | $129K | Hold |
1,407
| – | – | 0.1% | 159 |
|
|
2019
Q4 | $160K | Hold |
1,407
| – | – | 0.1% | 168 |
|
|
2019
Q3 | $153K | Sell |
1,407
-104
| -7% | -$10.9K | 0.1% | 151 |
|
|
2019
Q2 | $147K | Sell |
1,511
-5
| -0.3% | -$457 | 0.1% | 165 |
|
|
2019
Q1 | $138K | Hold |
1,516
| – | – | 0.1% | 162 |
|
|
2018
Q4 | $138K | Sell |
1,516
-23
| -1% | -$2.15K | 0.12% | 139 |
|
|
2018
Q3 | $152K | Buy |
1,539
+16
| +1% | +$1.48K | 0.11% | 158 |
|
|
2018
Q2 | $130K | Buy |
1,523
+805
| +112% | +$67.2K | 0.1% | 156 |
|
|
2018
Q1 | $57K | Buy |
718
+565
| +369% | +$46.6K | 0.04% | 190 |
|
|
2017
Q4 | $12K | Buy |
+153
| New | +$12.3K | 0.01% | 291 |
|
Other funds holding MDT
VCM
VPM
Global Trust Asset Management's MDT Position: Q1 2026 in Review
Global Trust Asset Management reduced its Medtronic (MDT) stake by 95% in Q1 2026, selling an estimated $1.37M and leaving 821 shares worth $71.1K. The position accounts for 0.03% of the portfolio, ranked #225.
Global Trust Asset Management first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.45M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Global Trust Asset Management held 821 shares of Medtronic worth $71.1K as of Q1 2026.
- Global Trust Asset Management sold 14,290 Medtronic shares in Q1 2026, an estimated $1.37M.
- Medtronic made up 0.03% of Global Trust Asset Management's portfolio in Q1 2026, its #225 holding.
- Global Trust Asset Management first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- Global Trust Asset Management's Medtronic position peaked at $1.45M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.